The activities of ERA4Health will support health care providers to better tackle, manage diseases and reduce the disease burden on patients effectively thanks to better understanding of prevention and treatment of diseases, more effective and innovative health technologies. In addition, a well-established collaboration in ERA4Health reinforces a European Research Area on health and brings better ability and preparedness to manage epidemic outbreaks and improved patient safety, thus contributing to an increased preparedness of EU health care systems for disease outbreaks.
In more details ERA4Health will lead to achieve the following impacts:
- improve the quality of research programming in the European Research and Innovation Area by building on best practices through networking European public funders of health research and will increase the outputs of the research and innovation discoveries for the benefit of society and economy.
- contribute to the transformation of healthcare systems in their efforts towards better health promotion and disease prevention while ensuring fair access for everyone to innovative, more patient oriented, sustainable (including from a fiscal point of view) and high-quality health care.
- contribute to living conditions that safeguard and promote health by positively impacting determinants of population health in relevant settings and on a variety of levels, including the local, regional, national and international level.
- increase knowledge on disease development and disease treatment that will lead to better prevention strategies, improved patient management and ultimately better health.
- contribute to effective, efficient, equitable, accessible, and resilient public health care systems that will be fiscally sustainable in the medium and long term. For example, the utilization of health services, preventative measures, technologies, tools and digital solutions will be more cost-effective.
- support the generation of findable, accessible, interoperable and reusable data, which at the same time will ensure appropriate protection of patients’ safety and rights, and data-driven approaches to confirm previous study or to respond to other research challenges and determine the effectiveness of other health interventions will reduce the research cost by avoiding effort duplication.
- improve the development of health strategies and innovations oriented towards public health needs in real-world settings. They will be more transferable and potentially useful as well as better accepted by end-users and will increase the scientific quality and societal relevance of produced knowledge, technologies and innovations, as for example by integrating an in-depth understanding of both genders’ needs, behaviours and attitudes. In addition, health strategies and innovations will be easier implemented in other regions/countries, in particular in the countries with the poorest specific health indicators.
- support citizens’ empowerment to make them more knowledgeable of disease threats and be able to make more conscious decisions for their health.
- facilitate more patient-oriented clinical research make citizens adhere to knowledge-based disease management strategies and policies (especially for controlling outbreaks and emergencies).
- contribute to breaking the glass ceiling in the long term by increasing the participation of women in research and by making women have a voice by achieving gender balance in decision making.
- contribute to the production of goods and services better suited to potential markets and will thereby contribute to the European economy.
- offer rapid and coordinated responses to cross border health emergencies once the network integrates the whole research and innovation actors.
